| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/08/2004 | US20040132018 Method of detecting risk factor for the onset of arteriosclerosis |
| 07/08/2004 | US20040132014 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
| 07/08/2004 | US20040132012 Nucleotide sequences consisiting of DNA viral open reading frames which code proteins which can be used to prepare genetic vaccines which prevent viral diseases |
| 07/08/2004 | US20040132010 Immunogen |
| 07/08/2004 | US20040132009 Foamy virus mutant reverse transcriptase |
| 07/08/2004 | US20040132007 Modified virus |
| 07/08/2004 | US20040131711 Bowman-birk inhibitor concentrate product and process |
| 07/08/2004 | US20040131640 Escape mutants of newcastle disease virus as marker vaccines |
| 07/08/2004 | US20040131639 Novel recombinant tryptophan mutants of influenza |
| 07/08/2004 | US20040131634 Neisseria lactoferrin binding protein |
| 07/08/2004 | US20040131633 Induce immunology response; polypeptide |
| 07/08/2004 | US20040131630 Administering a attenuated bacteria ; nucleic acids; induce immunology response |
| 07/08/2004 | US20040131626 Administering a genetic engineered polypeptide |
| 07/08/2004 | US20040131625 Vaccine composition |
| 07/08/2004 | US20040131624 Secreted chlamydia polypeptides and method for identifying such polypeptides by their secretion by a type lll secretion pathway of a gram-negative bacteria. |
| 07/08/2004 | US20040131618 Anticancer agents; diagnosis using alternation of gene expression |
| 07/08/2004 | US20040131616 Methods of inhibiting proliferative diseases |
| 07/08/2004 | US20040131601 Injection of bone marrow-derived cells and medium for angiogenesis |
| 07/08/2004 | US20040131600 Method of preventing adhesions by apoptosis of adhesion peritoneal cells |
| 07/08/2004 | US20040131598 Cancer therapy |
| 07/08/2004 | US20040131597 Human B-cell translocation genes-2 and 3 |
| 07/08/2004 | US20040131596 Method and compositions for modifying target receptor function associated with neurological disorders |
| 07/08/2004 | US20040131594 Malaria therapy; using pox virus vectors; genetic engineering; antitumor agents |
| 07/08/2004 | US20040131592 Gene expression of alphavirus; nucleotide sequences; induce immunology response; aids vaccine |
| 07/08/2004 | US20040131591 Vector system |
| 07/08/2004 | US20040131589 Materials and methods for inhibition of IgE production |
| 07/08/2004 | DE10260929A1 Verfahren zur Kontrolle von auf mikrobieller Interaktion beruhenden Vorgängen Control procedures based on microbial interaction processes |
| 07/08/2004 | DE10257771A1 Inhibierung der HIV Replikation durch Expression von 'late domain' Peptiden in Zielzellen Inhibition of HIV replication by expression of 'late domain' peptides in target cells |
| 07/08/2004 | DE10257770A1 Expression von Peptiden des zytoplasmatischen Bereiches von HIV-gp41 zur Hemmung viraler Infektionen Expression of peptides of the cytoplasmic region of HIV gp41 to inhibit viral infections |
| 07/08/2004 | DE10257421A1 Regulatorische Elemente im 5'-Bereich des VR1-Gens Regulatory elements in the 5 'region of the VR1 gene |
| 07/08/2004 | DE10257354A1 Isoliertes fluoreszierendes Protein CGFP, sowie dessen Verwendung An isolated fluorescent protein CGFP, and its use |
| 07/08/2004 | CA2512215A1 An immunomodulatory protein derived from trypanosomes and uses thereof |
| 07/08/2004 | CA2511777A1 Chorionic somatomammotropin hormone splice variants |
| 07/08/2004 | CA2511463A1 Plant genes and their use in controlling abcission in plants |
| 07/08/2004 | CA2511221A1 Plant with reduced protein content in seed, method of constructing the same and method of using the same |
| 07/08/2004 | CA2511144A1 Ghrelin receptor inverse agonist for regulation of feeding behaviours |
| 07/08/2004 | CA2510474A1 Pseudomonas aeruginosa and klebsiella virulence genes, proteins, and their use |
| 07/08/2004 | CA2510378A1 Preparation of antifreeze protein |
| 07/08/2004 | CA2510069A1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 07/08/2004 | CA2510046A1 Splice variant of human placental growth hormone |
| 07/08/2004 | CA2510029A1 Il-8-like proteins |
| 07/08/2004 | CA2509866A1 Mutations affecting carotenoid production |
| 07/08/2004 | CA2509840A1 Generation of plants with altered oil content comprising altered expression of a hio102 nucleic acid |
| 07/08/2004 | CA2509423A1 Peptides and their use for the treatment of hiv infections |
| 07/08/2004 | CA2507904A1 Cyanovirin variant-polymer conjugates |
| 07/08/2004 | CA2507637A1 Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors |
| 07/08/2004 | CA2507613A1 Methods of diagnosis and treatment of interstitial lung disease |
| 07/08/2004 | CA2505374A1 Melusin, a muscle specific protein, as a drug target for prevention and treatment of heart failure |
| 07/08/2004 | CA2501975A1 Recombinant virus production for the manufacturing of vaccines |
| 07/07/2004 | EP1435389A1 Method of evaluating efficacy of nucleic acid therapy |
| 07/07/2004 | EP1435361A2 6 human secreted proteins |
| 07/07/2004 | EP1435360A1 Novel peptide, novel adsorbent, adsorption unit and adsorption method |
| 07/07/2004 | EP1435243A2 Methods of alleviating cancer symtoms |
| 07/07/2004 | EP1435205A1 Plants which synthesise a modified starch, process for the production thereof and modified starch |
| 07/07/2004 | EP1434993A2 Methods of assaying connective tissue growth factor |
| 07/07/2004 | EP1434886A2 Mid 241 receptor, a novel g-protein coupled receptor |
| 07/07/2004 | EP1434885A2 21132, a human g-protein coupled receptor family member and uses therefor |
| 07/07/2004 | EP1434881A2 Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer |
| 07/07/2004 | EP1434879A2 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 07/07/2004 | EP1434875A1 Gene polymorphisms and response to treatment |
| 07/07/2004 | EP1434866A2 Genes associated with mast cell activation |
| 07/07/2004 | EP1434865A2 Variants and exons of the glyt1 transporter |
| 07/07/2004 | EP1434863A1 IDENTIFICATION AND USE OF MAMMALIAN p21 INHIBITORS |
| 07/07/2004 | EP1434862A2 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the cns |
| 07/07/2004 | EP1434860A2 Enzymes |
| 07/07/2004 | EP1434859A2 Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| 07/07/2004 | EP1434857A1 Method for production of recombinant proteins in eukaryote cells |
| 07/07/2004 | EP1434854A1 Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 07/07/2004 | EP1434801A2 Treatment for central nervous system disorders |
| 07/07/2004 | EP1434798A2 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells |
| 07/07/2004 | EP1434797A2 Insulin mimetic amino acid sequences |
| 07/07/2004 | EP1434796A2 Secreted proteins |
| 07/07/2004 | EP1434795A1 Asparagine hydroxylation of the cad domain of a hif protein |
| 07/07/2004 | EP1434794A2 Fragments of heat shock proteins and their use |
| 07/07/2004 | EP1434793A1 RECOMBINANT ALLERGEN WITH REDUCED IgE BINDING BUT UNDIMINISHED T-CELL ANTIGENICITY |
| 07/07/2004 | EP1434791A2 Specific binding agents of human angiopoietin-2 |
| 07/07/2004 | EP1434790A1 Calcium-influx inhibitory factor and method of isolation thereof |
| 07/07/2004 | EP1434789A2 Improved protein disaggregation and refolding using high pressure |
| 07/07/2004 | EP1434788A2 Proteins associated with cell growth, differentiation, and death |
| 07/07/2004 | EP1434787A2 Lp mammalian proteins; related reagents |
| 07/07/2004 | EP1434785A2 Protein modification and maintenance molecules |
| 07/07/2004 | EP1434783A2 Lp mammalian proteins; related reagents |
| 07/07/2004 | EP1434599A1 Human 3 relaxin |
| 07/07/2004 | EP1434598A2 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis |
| 07/07/2004 | EP1434592A1 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer |
| 07/07/2004 | EP1434589A2 Thioester-terminated water soluble polymers and method of modifying the n-terminus of a polypeptide therewith |
| 07/07/2004 | EP1434493A1 Flax protein isolate and production |
| 07/07/2004 | EP1434483A2 NUCLEIC ACIDS ENCODING LINKED CHROMO/FLUORESCENT DOMAINS AND METHODS FOR USING THE SAME |
| 07/07/2004 | EP1434482A2 Methods for growing and imprinting fish using an odorant |
| 07/07/2004 | EP1412517A4 Methods, kits and compositions of combination oligomers |
| 07/07/2004 | EP1387884A4 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
| 07/07/2004 | EP1333871A4 Hydrophobic multicomponent heparin conjugates, a preparing method and a use thereof |
| 07/07/2004 | EP1181393A4 CRYSTAL STRUCTURE OF RIBOSOMAL PROTEIN L11/GTPASE ACTIVATING REGION rRNA AND USES THEREOF |
| 07/07/2004 | EP1100912B1 Method for screening of modulators of calcineurin activity |
| 07/07/2004 | EP0750743B1 Method and device for automatic assessment of corn |
| 07/07/2004 | CN1511044A Elogated and multiple spacers in activatible prodrugs |
| 07/07/2004 | CN1511041A Methods of treating antibody-mediated pathologies using agents which inhibit CD 21 |
| 07/07/2004 | CN1511040A Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 07/07/2004 | CN1510147A Determination of alpha-N-acetamino galactosidase activity |
| 07/07/2004 | CN1510145A Method for producing polypeptide in bacillocin cell |